We aimed to evaluate how myo-inositol supplementation affects women with gestational diabetes through a meta-analysis of randomized controlled trials. Our search included multiple databases, leading to the analysis of four studies involving 317 participants. The results showed that myo-inositol significantly reduced the need for insulin and improved insulin sensitivity. However, it did not influence birth weight, cesarean delivery rates, or NICU admissions. These findings suggest myo-inositol could be a helpful addition to managing gestational diabetes, but further research is needed.
Read More
9.5
Inositol reduces gestational diabetes risk
Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
8
Myo-inositol improves glycemic control
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial.
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Read More
Most Useful Reviews
6
Increased energy
Recommended by my primary care physician years ago, niacin has helped me gain energy and manage my Type 2 diabetes. I inquired about specific brands she recommended, and she mentioned Now. Now, it has become my preferred daily B vitamin, and it genuinely helps boost my strength, which is vital at my age.
Read More
0
Blood sugar concern
After I purchased it, I discovered that it raises blood sugar levels. As I have diabetes, I am reluctant to consume it. What a waste.
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
9
New drug shows promise for diabetes
Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes.
We evaluated the effectiveness of Xelaglifam, a new drug designed to activate specific receptors that help manage Type 2 diabetes. Our study compared its performance against another drug, Fasiglifam.
Through tests in the lab and on rats, we found that Xelaglifam boosts insulin secretion and lowers blood sugar levels effectively without causing hypoglycemia.
Additionally, its ability to improve glucose tolerance suggests it could be a valuable treatment option for those managing this condition, potentially working well alongside existing medications.
Read More
8
D-Pinitol and ice plant benefits
The Glucose-Lowering Effect of and D-Pinitol: Studies on Insulin Secretion in INS-1 Cells and the Reduction of Blood Glucose in Diabetic Rats.
We explored the effects of ice plant extract and its compound D-pinitol on insulin secretion and blood sugar levels in diabetic rats. By utilizing the glucose-stimulated insulin secretion test and measuring various insulin-related factors, we discovered that both substances significantly boosted insulin secretion.
Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
Read More
8
Histatin 1 enhances diabetic wound healing
Human salivary histatin 1 regulating IP3R1/GRP75/VDAC1 mediated mitochondrial-associated endoplasmic reticulum membranes (MAMs) inhibits cell senescence for diabetic wound repair.
We explored how Histatin 1, found in human saliva, helps combat aging in human umbilical vein endothelial cells (HUVECs) to improve diabetic wound healing. The study revealed that this peptide reduces cell senescence and works by enhancing mitochondrial function and reducing oxidative stress.
In laboratory settings, Histatin 1 decreased markers of aging in cells and improved their function. Furthermore, in a mouse model of diabetes, it promoted wound healing through increased blood vessel formation.
Overall, Histatin 1 shows promise as a solution for improving skin repair in diabetic patients.
Read More
8
Myo-inositol improves glycemic control
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial.
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Recommended by my primary care physician years ago, niacin has helped me gain energy and manage my Type 2 diabetes. I inquired about specific brands she recommended, and she mentioned Now. Now, it has become my preferred daily B vitamin, and it genuinely helps boost my strength, which is vital at my age.
Read More
0
Blood sugar concern
After I purchased it, I discovered that it raises blood sugar levels. As I have diabetes, I am reluctant to consume it. What a waste.
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
Lee D, Kim SJ, Choi YJ, Rho YH, Kang TS, et al. The Glucose-Lowering Effect of and D-Pinitol: Studies on Insulin Secretion in INS-1 Cells and the Reduction of Blood Glucose in Diabetic Rats. Nutrients. 2025;17. 10.3390/nu17010193
Xian T, Liu Y, Ye Y, Peng B, Huang J, et al. Human salivary histatin 1 regulating IP3R1/GRP75/VDAC1 mediated mitochondrial-associated endoplasmic reticulum membranes (MAMs) inhibits cell senescence for diabetic wound repair. Free Radic Biol Med. 2024;225:164. 10.1016/j.freeradbiomed.2024.09.046
Asimakopoulos G, Pergialiotis V, Antsaklis P, Theodora M, Loutradis D, et al. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial. Arch Gynecol Obstet. 2024;310:1895. 10.1007/s00404-024-07618-8
Chen H, Xiong J, Li Z, Chen Y, Zhang M, et al. Influence of myo-inositol on metabolic status for gestational diabetes: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2024;37:2228450. 10.1080/14767058.2023.2228450
Yoon J, Lee DG, Song H, Hong D, Park JS, et al. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes. Biomed Pharmacother. 2024;177:117044. 10.1016/j.biopha.2024.117044
Long L, Huang Q, Song T, Dai Z. Myo-inositol rescued insulin resistance and dyslipidemia in db/db mice. J Appl Biomed. 2024;22:74. 10.32725/jab.2024.009
Aguilar-Guadarrama AB, Díaz-Román MA, Osorio-García M, Déciga-Campos M, Rios MY. Chemical Constituents from Agave applanata and Its Antihyperglycemic, Anti-inflammatory, and Antimicrobial Activities Associated with Its Tissue Repair Capability. Planta Med. 2024;90:397. 10.1055/a-2270-5527
Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, et al. Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Blume and Inulin in Patients with Metabolic Syndrome. Nutrients. 2024;16. 10.3390/nu16020249
Factor PA, Corpuz H. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. J ASEAN Fed Endocr Soc. 2023;38:102. 10.15605/jafes.038.02.11
Greff D, Váncsa S, Váradi A, Szinte J, Park S, et al. Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2023;15. 10.3390/nu15194224